Federal legalization of cannabis could reduce sales of conventional drugs by billions of dollars for a new one to learn conducted by researchers at California Polytechnic State University and the University of New Mexico.
The studyentitled “US Cannabis Laws Projected to Cost Generic and Brand Pharmaceutical Firms Billion”, examined the performance of publicly traded pharmaceutical companies after legalization measures for medical or recreational purposes.
Ziemowit Bednarek from the Finance Department of California Polytechnic State University, Sarah Stith from the University of New Mexico Economics Department, and a co-author corroborated this Pharma stocks had 1.5-2% lower returns in just 10 days after marijuana legalization, writes UNM Newsroom.
In addition, the results showed these reductions caused Loss of billions in annual sales.
While other studies have shown how marijuana Access has lowered the use of certain medications, such as opioids, or reduced use in certain patient groups, such as Medicaid patients, this is said to be the first study of its kind to examine the broader impact of marijuana on pharmaceutical companies across all types of patients.
Why is the effect of a plant so overwhelming?
Cannabis versus Standard Drugs – Incomparable
That’s because cannabis is an amazing plant consists of many connections that affect our bodies and minds differently. As such, it’s often used to treat a variety of conditions, from anxiety and sleep disorders to headaches and muscle spasms, not to mention more serious conditions like certain types of epilepsy. Compared to all the other drugs designed to target specific conditions or symptoms, it’s easy to see why marijuana’s effects are so powerful.
Added to this is the price of medicines, which is often a struggle for many Americans and a financial drain on the federal government. Because of this, many see marijuana as a great way to…
